Ambrisentan Tablets and Methylphenidate Extended-Release Tablets
Determining the interaction of Ambrisentan Tablets and Methylphenidate Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Methylphenidate Hydrochloride
- Ambrisentan Tablets-Methylphenidate LA Capsules
- Ambrisentan Tablets-Methylphenidate Oral Solution
- Ambrisentan Tablets-Methylphenidate Oral, Transdermal
- Ambrisentan Tablets-Methylphenidate Tablets
- Ambrisentan Tablets-Methylphenidate transdermal
- Methylphenidate Extended-Release Tablets-Amcinonide
- Methylphenidate Extended-Release Tablets-Amcinonide Cream and Ointment
- Methylphenidate Extended-Release Tablets-Amcinonide Lotion
- Methylphenidate Extended-Release Tablets-Amcinonide Ointment
- Methylphenidate Extended-Release Tablets-Amcinonide topical
- Methylphenidate Extended-Release Tablets-Amcinonide Topical application